The Changing Landscape of Prescription Drug Benefits: Employers and Unions Take Control

The Changing Landscape of Prescription Drug Benefits: Employers and Unions Take Control

Introduction:
The complex world of prescription drug benefits has long been a source of frustration for employers and unions. With rising drug costs and opaque pricing practices, many organizations are searching for alternatives to traditional drug-benefit managers. In recent years, we have witnessed a series of significant developments that are reshaping this under-the-radar sector. From high-profile companies dropping their drug-benefit managers to new players entering the market, the landscape is undergoing a transformation. In this article, we will explore the concerns of employers and unions, the impact of alternative pharmacy benefit managers, and the potential for change in controlling spending on retail prescription drugs.

Concerns over Rising Costs and Lack of Transparency:
Employers and unions have raised concerns about getting stuck with higher-cost drugs due to the rebates pocketed by drug-benefit managers. The lack of transparency around fees and other sources of revenue has made it difficult for organizations to determine the true cost of prescription drugs. This opacity has fueled frustration among employers and unions, who argue that they are unable to make informed decisions about drug benefits. With drug spending projected to reach $411.6 billion this year, the need for cost control and transparency is more pressing than ever.

The Rise of Alternative Pharmacy Benefit Managers:
In response to the frustrations of employers and unions, alternative pharmacy benefit managers have emerged in the market. Foot Locker, a well-known footwear retailer, made headlines when it dropped UnitedHealth Group's OptumRx as its drug-benefit manager. Instead, Foot Locker opted for Navitus Health Solutions, a smaller pharmacy benefit manager that promises to pass through 100% of the drug rebates it negotiates. The move had a significant impact, with drug spending dropping by 5% within the first year. Similarly, the Teamsters fund in Philadelphia switched from CVS Health's Caremark to Capital Rx, another PBM that guarantees the pass-through of rebates. The executive director of the Teamsters fund hailed the decision as the "best decision ever." These success stories highlight the potential of alternative PBMs to address the concerns of employers and unions.

Walgreens' Acquisition of Shields Health Solutions:
In another notable development, Walgreens Boots Alliance announced its acquisition of Shields Health Solutions for $1.37 billion. Shields, a specialty pharmacy company, will continue to operate as a distinct business and brand within Walgreens. The co-founder and current president of Shields, John Lucey, will assume the role of CEO, while the current CEO, Lee Cooper, will transition to a new executive role within Walgreens. This acquisition demonstrates the growing influence of retail pharmacies in the pharmacy benefit management space. By integrating specialty pharmacy services, Walgreens aims to provide a comprehensive solution for employers and unions seeking more control over their prescription drug benefits.

Actionable Advice for Employers and Unions:

1. Evaluate transparency and fee structures: When considering a drug-benefit manager, employers and unions should prioritize transparency and understand the fee structure. Seek out PBMs that provide clear information about fees and revenue sources to make informed decisions about drug benefits.

2. Explore alternative pharmacy benefit managers: Consider partnering with smaller PBMs that prioritize passing through all negotiated rebates. The success stories of Foot Locker and the Teamsters fund demonstrate the potential for cost savings and improved drug benefits with alternative PBMs.

3. Embrace partnerships with retail pharmacies: With the acquisition of Shields Health Solutions, Walgreens signifies the growing role of retail pharmacies in the PBM sector. Employers and unions should explore collaborations with retail pharmacies to access a comprehensive suite of services and gain more control over prescription drug benefits.

Conclusion:
The frustrations of employers and unions with traditional drug-benefit managers are driving significant changes in the pharmacy benefit management landscape. From dropping established PBMs to embracing alternative pharmacy benefit managers and forming new partnerships, organizations are taking control of their prescription drug benefits. By prioritizing transparency, exploring alternative PBMs, and considering collaborations with retail pharmacies, employers and unions can navigate the evolving landscape to enhance cost control and improve drug benefits for their workers. As the sector continues to evolve, it is crucial for organizations to stay informed and proactive in shaping their prescription drug benefit strategies.